181 related articles for article (PubMed ID: 12428662)
1. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs.
Jones CJ; Streppa HK; Harmon BG; Budsberg SC
Am J Vet Res; 2002 Nov; 63(11):1527-31. PubMed ID: 12428662
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis.
Sessions JK; Reynolds LR; Budsberg SC
Am J Vet Res; 2005 May; 66(5):812-7. PubMed ID: 15934608
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of tepoxalin, an inhibitor of cyclooxygenase and lipoxygenase, on prostanoid and leukotriene production in dogs with chronic osteoarthritis.
Agnello KA; Reynolds LR; Budsberg SC
Am J Vet Res; 2005 Jun; 66(6):966-72. PubMed ID: 16008217
[TBL] [Abstract][Full Text] [Related]
4. Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs.
Punke JP; Speas AL; Reynolds LR; Budsberg SC
Am J Vet Res; 2008 Sep; 69(9):1203-9. PubMed ID: 18764695
[TBL] [Abstract][Full Text] [Related]
5. Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.
Goodman LA; Torres BT; Reynolds LR; Budsberg SC
Am J Vet Res; 2010 Sep; 71(9):1067-73. PubMed ID: 20807147
[TBL] [Abstract][Full Text] [Related]
6. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
[TBL] [Abstract][Full Text] [Related]
8. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
Stichtenoth DO; Wagner B; Frölich JC
J Investig Med; 1997 Feb; 45(2):44-9. PubMed ID: 9084574
[TBL] [Abstract][Full Text] [Related]
9. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
[TBL] [Abstract][Full Text] [Related]
10. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
Engelhardt G; Bögel R; Schnitzler C; Utzmann R
Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
[TBL] [Abstract][Full Text] [Related]
11. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
[TBL] [Abstract][Full Text] [Related]
12. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers.
Van Ryn J; Kink-Eiband M; Kuritsch I; Feifel U; Hanft G; Wallenstein G; Trummlitz G; Pairet M
J Clin Pharmacol; 2004 Jul; 44(7):777-84. PubMed ID: 15199082
[TBL] [Abstract][Full Text] [Related]
13. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
14. Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants.
Moses VS; Hardy J; Bertone AL; Weisbrode SE
Am J Vet Res; 2001 Jan; 62(1):54-60. PubMed ID: 11197561
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer.
Pairet M; van Ryn J; Schierok H; Mauz A; Trummlitz G; Engelhardt G
Inflamm Res; 1998 Jun; 47(6):270-6. PubMed ID: 9683035
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.
Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D
Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909
[TBL] [Abstract][Full Text] [Related]
17. Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production.
Wight NJ; Gottesdiener K; Garlick NM; Atherton CT; Novak S; Gertz BJ; Calder NA; Cote J; Wong P; Dallob A; Hawkey CJ
Gastroenterology; 2001 Mar; 120(4):867-73. PubMed ID: 11231941
[TBL] [Abstract][Full Text] [Related]
18. Aspirin, but not the more selective cyclooxygenase (COX)-2 inhibitors meloxicam and SC 58125, aggravates postischaemic cardiac dysfunction, independent of COX function.
Heindl B; Becker BF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):233-40. PubMed ID: 11218076
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs.
Kay-Mugford P; Benn SJ; LaMarre J; Conlon P
Am J Vet Res; 2000 Jul; 61(7):802-10. PubMed ID: 10895904
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
